[Who are the candidates for the treatment by raloxifen ?].
There is evidence that raloxifene prevents vertebral fracture and it improves bone metabolism in patients with osteoporosis to the normal pre-menopausal level. Therefore, it is suitable to use for osteoporotic patients with adequate physical activity and those improvable by exercise. Patients who will be treated by anabolic agents are also good candidates for the treatment of raloxifene.
Hagino
Hiroshi
H
Rehabilitation Division, Tottori University Hospital.
D000367:Age Factors; D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism; D004035:Diet Therapy; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009043:Motor Activity / Q000502:physiology; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D018579:Patient Selection; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
D010281:Parathyroid Hormone; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D019386:Alendronate